Burcon Announces New Board Members and Results of Shareholder Meeting
Burcon NutraScience (OTCQB: BRCNF), a global plant-based protein innovation leader, has appointed two new board members and announced its 2025 AGM results. Philip Dowad, a former KPMG audit partner with 43 years of experience in securities regulation, and Richard Nazur Jr., an agricultural commodity markets expert with over 20 years of experience, have joined the board.
At the AGM, all seven director nominees were successfully elected, with approval rates ranging from 71.72% to 99.45%. Shareholders also approved KPMG LLP as auditors and amended the exercise price of outstanding warrants. Mr. Dowad brings expertise in Canadian and U.S. securities requirements, while Mr. Nazur contributes extensive knowledge in global agricultural commodities trading and markets across five continents.
Burcon NutraScience (OTCQB: BRCNF), leader globale nell'innovazione delle proteine vegetali, ha nominato due nuovi membri del consiglio e ha comunicato i risultati dell'AGM 2025. Philip Dowad, ex partner di KPMG con 43 anni di esperienza in regolamentazione dei titoli, e Richard Nazur Jr., esperto di mercati delle commodities agricole con oltre 20 anni di esperienza, si sono uniti al consiglio.
All'AGM, tutti i sette candidati al consiglio sono stati eletti con tassi di approvazione che vanno dal 71,72% al 99,45%. Gli azionisti hanno anche approvato KPMG LLP come revisori e modificato il prezzo di esercizio delle warrant in circolazione. Il signor Dowad porta competenze nei requisiti di titoli canadesi e statunitensi, mentre il signor Nazur apporta un'ampia conoscenza del commercio di commodities agricole e dei mercati globali su cinque continenti.
Burcon NutraScience (OTCQB: BRCNF), líder global en innovación de proteínas vegetales, ha nombrado a dos nuevos miembros de la junta y anunció los resultados de la AGE de 2025. Philip Dowad, ex socio de auditoría de KPMG con 43 años de experiencia en regulación de valores, y Richard Nazur Jr., experto en mercados de productos agrícolas con más de 20 años, se han incorporado a la junta.
En la AGE, los siete candidatos a la dirección fueron elegidos con éxito, con tasas de aprobación que oscilan entre 71,72% y 99,45%. Los accionistas también aprobaron a KPMG LLP como auditores y enmendaron el precio de ejercicio de las warrants existentes. El Sr. Dowad aporta experiencia en los requisitos de valores canadienses y estadounidenses, mientras que el Sr. Nazur aporta amplio conocimiento en comercio global de materias primas agrícolas y mercados en cinco continentes.
Burcon NutraScience (OTCQB: BRCNF)는 세계적인 식물성 단백질 혁신의 선두주자로서 두 명의 이사를 새로 선임하고 2025년 연차총회(AGM) 결과를 발표했습니다. Philip Dowad는 증권 규제 분야에서 43년의 경력을 가진 전 KPMG 감사 파트너이며, Richard Nazur Jr.는 20년이 넘는 경력을 가진 농산물 상품 시장 전문가로 이사회에 합류했습니다.
연차 총회에서 7명의 이사 후보는 모두 선출되었고 승인율은 71.72%에서 99.45%까지 다양했습니다. 주주들은 또한 KPMG LLP를 감사인으로 승인했고 발행 워런트의 행사 가격을 수정했습니다. Dowad 씨는 캐나다와 미국의 증권 요건에 대한 전문 지식을 가져오고, Nazur 씨는 다섯 대륙에 걸친 글로벌 농산물 거래 및 시장에 대한 폭넓은 지식을 기여합니다.
Burcon NutraScience (OTCQB: BRCNF), leader mondial de l'innovation des protéines d'origine végétale, a nommé deux nouveaux administrateurs et a annoncé les résultats de l'AG annuelle 2025. Philip Dowad, ancien partenaire d'audit chez KPMG avec 43 ans d'expérience en réglementation des valeurs mobilières, et Richard Nazur Jr., expert des marchés des matières premières agricoles avec plus de 20 ans d'expérience, ont rejoint le conseil d'administration.
Lors de l'AGA, les sept candidats au conseil ont tous été élus, avec des taux d'approbation allant de 71,72 % à 99,45 %. Les actionnaires ont également approuvé KPMG LLP en tant qu'auditeurs et modifié le prix d'exercice des warrants en circulation. M. Dowad apporte une expertise en exigences relatives aux titres canadiens et américains, tandis que M. Nazur apporte une connaissance approfondie du commerce international des matières agricoles et des marchés sur les cinq continents.
Burcon NutraScience (OTCQB: BRCNF), ein weltweit führendes Unternehmen in der pflanzenbasierten Proteininnovation, hat zwei neue Vorstandsmitglieder ernannt und die Ergebnisse der Hauptversammlung 2025 bekannt gegeben. Philip Dowad, ehemaliger KPMG-Prüferpartner mit 43 Jahren Erfahrung in der Wertpapieraufsicht, und Richard Nazur Jr., ein Experte für globale Agrarrohstoffmärkte mit über 20 Jahren Erfahrung, sind dem Vorstand beigetreten.
Bei der GV wurden alle sieben Direktornominierungen erfolgreich gewählt, mit Zustimmungsraten von 71,72% bis 99,45%. Die Aktionäre billigten außerdem KPMG LLP als Wirtschaftsprüfer und änderten den Ausübungspreis der ausstehenden Warrants. Mr. Dowad bringt Fachwissen zu kanadischen und US-Wertpapieranforderungen mit, während Mr. Nazur umfangreiche Kenntnisse im globalen Handel mit landwirtschaftlichen Rohstoffen und Märkten auf fünf Kontinenten beisteuert.
بوركون نترا ساينس (OTCQB: BRCNF)، الرائدة العالمية في ابتكار البروتينات النباتية، تعيّن عضوين جديدين في مجلس الإدارة وتعلن عن نتائج الجمعية العامة لعام 2025. Philip Dowad، شريك تدقيق سابق في كي بي إم جي ولديه 43 عامًا من الخبرة في تنظيم الأوراق المالية، وRichard Nazur Jr.، خبير أسواق السلع الزراعية بأكثر من 20 عامًا من الخبرة، انضموا إلى المجلس.
في الجمعية، تم انتخاب جميع المرشحين السبعة للمجلس بنجاح، بمعدلات موافقة تراوحت بين 71.72% إلى 99.45%. كما وافق المساهمون على كي بي ام جي LLP كمدققين ووافقوا على تعديل سعر ممارسة المنذرات القائمة. يجلب السيد Dowad خبرة في متطلبات الأوراق المالية الكندية والأمريكية، بينما يضيف السيد Nazur معرفة واسعة في التجارة بالسلع الزراعية والأسواق العالمية عبر خمس قارات.
Burcon NutraScience (OTCQB: BRCNF)，全球植物性蛋白创新的领导者，任命了两名新董事会成员并宣布了2025年年度股东大会（AGM）的结果。Philip Dowad，曾任KPMG审计合伙人，拥有43年的证券监管经验；Richard Nazur Jr.，拥有超过20年的全球农业大宗商品市场经验，已加入董事会。
在AGM上，七位董事提名人全部成功当选，获批率介于71.72%至99.45%之间。股东还批准KPMG LLP担任审计师，并修改了在案认股权证的行使价格。Dowad先生在加拿大和美国证券要求方面具备专业知识，而Nazur先生则在全球五大洲的农业大宗商品贸易与市场方面贡献了丰富经验。
- Addition of two highly experienced board members with complementary expertise in securities regulation and agricultural commodities
- Strong shareholder support with most directors receiving over 97% approval votes
- Appointment of Big Four firm KPMG LLP as auditors, enhancing financial oversight
- Relatively lower shareholder approval (71.72%) for new director Philip Dowad compared to other board members
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce Mr. Philip Dowad and Mr. Richard Nazur Jr. as new members of its Board of Directors.
"We are very pleased to welcome Phil and Richard to our board as we enter the next phase of growth," said Peter H. Kappel, Chair of Burcon's board of directors. "Phil brings extensive experience in Canadian and U.S. securities regulatory requirements, while Richard offers deep expertise in agricultural commodity markets. Their guidance will be invaluable, and I look forward to their contributions to our board and management team."
AGM Results
The Company also announces the results from its 2025 annual general and special meeting of shareholders (the "Meeting") held on September 17, 2025. All of the seven nominees set out in Burcon's management proxy circular dated August 1, 2025 proposed by management for election to the board of directors at the Meeting were elected to the board. Each director elected will hold office until the conclusion of the next annual general meeting of shareholders of Burcon or until his or her successor is elected or appointed, unless his or her office is earlier vacated in accordance with Burcon's articles or with applicable law.
The results of the voting on the election of the directors are as follows:
| Director Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld | Non Votes |
| Alan Chan | 5,792,102 | 32,166 | 178,446 | ||
| Peter H. Kappel | 5,776,452 | 47,816 | 178,446 | ||
| Jeanne McCaherty | 5,775,554 | 48,714 | 178,446 | ||
| John A. Vassallo | 5,675,004 | 149,264 | 178,446 | ||
| James Peter Pekar | 5,754,683 | 69,585 | 178,446 | ||
| Philip James Dowad | 4,177,313 | 1,646,955 | 178,446 | ||
| Richard Nazur Jr. | 5,763,535 | 60,733 | 178,446 |
Shareholders of the Company also approved the appointment of KPMG LLP as auditors of the Company and the amendment to the exercise price of its outstanding warrants.
Philip Dowad Bio
Phil Dowad was an audit and professional practice partner of KPMG with over 43 years of experience working with global companies primarily based out of locations across Canada. He held senior positions within KPMG including as a Canadian and U.S. securities partner reviewing filing documents prior to their filing with securities regulators in both countries. Since his retirement in 2022, Mr. Dowad has acted as a consultant to North American based entities as well as acting as an expert witness in certain litigation matters. Mr. Dowad is a former director and Chairman of the Audit Committee of the YMCA of Greater Vancouver.
Richard Nazur Jr. Bio
Mr. Nazur has been involved in the agricultural commodity markets for over 20 years, beginning his career at Archer Daniels Midland Company ("ADM"). During his six years at ADM, Mr. Nazur was involved in nine different agricultural commodities leveraging all logistical conveyances in North America. Being a global food processing powerhouse, ADM's Ag services unit oversaw arbitraging global commodity markets for both profit and to secure supplies for the vast network of processing facilities. Prior to his departure from ADM, Mr. Nazur was Wheat Commodity Line Manager and oversaw ADM's North American wheat trading and logistics segments. In 2012, Mr. Nazur left ADM and became an independent commodity futures trader. In the last 13 years, Mr. Nazur has applied the experience gained over his career to build a successful family office that is actively involved in over ten different commodity markets that span across five different continents and is a regular commentator on various nationally broadcasted agricultural shows.
About Burcon NutraScience Corporation
Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
490 - 999 West Broadway, Vancouver, BC, V5Z 1K5
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266880
FAQ
Who are the new board members appointed to Burcon NutraScience (BRCNF)?
What was the voting outcome for Burcon's 2025 AGM director elections?
What is Philip Dowad's background and experience at KPMG?
What is Richard Nazur Jr.'s experience in agricultural commodities?
What additional matters were approved at Burcon's 2025 AGM?
